Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer
XOVOLTIB
XOVOLTIB belongs to a class of drugs known as kinase inhibitors,it is the first-line treatment for patients with metastatic non-small cell lung cancer whose tumors have non-resistant EGFR mutations.
Trade name
XOVOLTIB
Manufacturer
BOEHRINGER INGELHEIM
Main ingreadient
AFATINIB
Specification
Not Available
Logistics
Please discuss the logistics method with the customer service executive on customer service whatsapp/wechat/zalo/viber account
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
XOVOLTIB belongs to a class of drugs known as kinase inhibitors,it is
the first-line treatment for patients with metastatic non-small cell
lung cancer whose tumors have non-resistant EGFR mutations.XOVOLTIB is a
second-generation EGFR TKI which Unlike first-generation TKIs such as
gefitinib, is an ErbB family blocker which irreversibly blocks signaling
from all relevant homodimers and heterodimers of the ErbB family of
receptors
The recommended dosage of XOVOLTIB is 40 mg orally once daily until disease progression or no longer tolerated by the patient.